Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Modern Pathology

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.3800287PMID 15467712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor*

  2003cited by this paper
• Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

  2003cited by this paper
• Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms

  2003cited by this paper
• Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.

  2003cited by this paper
• Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours

  2003cited by this paper
• Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma

  2003cited by this paper
• Identification of a novel Ras-regulated proapoptotic pathway.

  2002cited by this paper
• The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.

  2002cited by this paper
• Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.

  2002cited by this paper
• The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

  2002cited by this paper
• K-ras mutations and RASSF1A promoter methylation in colorectal cancer

  2002cited by this paper
• Cellular and molecular biology of biliary tract cancers.

  2002cited by this paper
• Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.

  2002cited by this paper
• Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.

  2001cited by this paper
• Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

  2001cited by this paper
• Altered Expression of β-Catenin without Genetic Mutation in Intrahepatic Cholangiocarcinoma

  2001cited by this paper
• Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

  2001cited by this paper
• Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

  2001cited by this paper
• Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

  2001cited by this paper
• Promoter-region hypermethylation and gene silencing in human cancer.

  2000cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver

  2000cited by this paper
• Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis*

  2000cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

  2000cited by this paper
• Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.

  1999cited by this paper
• Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.

  1999cited by this paper
• Alterations of the p53 tumor‐suppressor gene and K‐ ras oncogene in perihilar cholangiocarcinomas from a high‐incidence area

  1998cited by this paper
• The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.

  1998cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand

  1993cited by this paper

• Microscopically Incomplete Resection (R1) of Intrahepatic Cholangiocarcinoma: What’s the Next Step?

  2026cites this paper
• MicroRNA-1 Suppresses Tumor Progression and UHRF1 Expression in Cholangiocarcinoma

  2025cites this paper
• Morphologic and molecular diagnostic criteria of malignancies in biliary strictures.

  2024cites this paper
• Utility of methylated DNA markers for the diagnosis of malignant biliary strictures.

  2024cites this paper
• Wnt/β-Catenin Signaling in Liver Pathobiology.

  2024cites this paper
• Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity

  2023cites this paper
• Epigenetic Aspects and Prospects in Autoimmune Hepatitis

  2022cites this paper
• The Molecular Pathogenesis and Targeted Therapies for Cholangiocarcinoma.

  2022cites this paper
• DNA methylation in cell plasticity and malignant transformation in liver diseases.

  2022cites this paper
• Involvement of Epigenomic Factors in Bile Duct Cancer.

  2022cites this paper
• MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers

  2022cites this paper
• Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort

  2022cites this paper
• Epigenetics in hepatoblastoma

  2021cites this paper
• Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies

  2021cites this paper
• Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology

  2021cites this paper
• Cholangiocarcinoma and liver transplantation: What we know so far?

  2021cites this paper
• Risk factors for preoperative carcinogenesis of bile duct cysts in adults

  2021cites this paper
• The Investigative Therapeutic Pipeline for Cholangiocarcinoma: Insights from Model Systems

  2021cites this paper
• Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients

  2021cites this paper
• Optimal tissue sampling during ERCP and emerging molecular techniques for the differentiation of benign and malignant biliary strictures

  2021cites this paper
• Current challenges to underpinning the genetic basis for cholangiocarcinoma

  2021cites this paper
• Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

  2020cites this paper
• Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers

  2020cites this paper
• Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21

  2020cites this paper
• IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives

  2020cites this paper
• Epigenetic based synthetic lethal strategies in human cancers

  2020cites this paper
• Predictors of adjuvant treatment and survival in patients with intrahepatic cholangiocarcinoma who undergo resection.

  2019cites this paper
• Medical treatment for cholangiocarcinoma

  2019cites this paper
• Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma

  2019cites this paper
• The promising role of epigenetic mediators and microRNAs in the early diagnosis of cholangiocarcinoma (Review)

  2019cites this paper
• Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.

  2019cites this paper
• Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine

  2019cites this paper
• Epigenetic changes and their implications in autoimmune hepatitis

  2018cites this paper
• Emerging role of precision medicine in biliary tract cancers

  2018cites this paper
• Intrahepatic cholangiocarcinoma: review and update

  2018cites this paper
• An Effective Concentration of 5-Aza-CdR to Induce Cell Death and Apoptosis in Human Pancreatic Cancer Cell Line through Reactivating RASSF1A and Up-Regulation of Bax Genes

  2018cites this paper
• Mechanisms of Gastrointestinal Malignancies

  2018cites this paper
• New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin

  2017cites this paper
• Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4

  2017cites this paper
• Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.

  2017cites this paper
• DNA Methylation Markers Improve the Sensitivity of Endoscopic Retrograde Cholangiopancreatography-Based Brushing Cytology in Extrahepatic Cholangiocarcinoma

  2017cites this paper
• Mutations of candidate tumor suppressor genes at chromosome 3p in intrahepatic cholangiocarcinoma.

  2017cites this paper
• Amplification and overexpression of the MET gene in intrahepatic cholangiocarcinoma correlate with adverse pathological features and worse clinical outcome

  2017cites this paper
• Growth Regulation in Hepatobiliary Cancer: Regulators of the Cell Division Cycle

  2016cites this paper
• Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract

  2016cites this paper
• The pathways of genetic transformation in cholangiocarcinogenesis.

  2016cites this paper
• Etiology and Pathogenic Pathways of Cholangiocarcinoma

  2016cites this paper
• Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers.

  2015cites this paper
• Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3′-shore

  2015cites this paper
• Epigenetic regulation in the carcinogenesis of cholangiocarcinoma.

  2015cites this paper
• Expression of p16 protein in infantile hemangioma.

  2015cites this paper
• Molecular pathogenesis of intrahepatic cholangiocarcinoma

  2015cites this paper
• Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.

  2015cites this paper
• Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma

  2015cites this paper
• Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells.

  2015cites this paper
• Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.

  2015cites this paper
• Epstein–Barr virus‐associated lymphoepithelioma‐like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome

  2014influential citation
• si-DNMT1 restore tumor suppressor genes expression through the reversal of DNA hypermethylation in cholangiocarcinoma.

  2014cites this paper
• Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.

  2014cites this paper
• Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway

  2014cites this paper
• Evaluating DAPK as a therapeutic target

  2014cites this paper
• Rôle des protéines AID et Bfl-1 dans les processus d'instabilité génomique et de survie cellulaire induits par l'oncoprotéine Tax au cours de la lymphomagénèse associée à l'infection par HTLV-1

  2014influential citation
• Comparison of the anti-cancer effect of Disulfiram and 5-Aza-CdR on pancreatic cancer cell line PANC-1

  2014cites this paper
• The role of RASSF 1 A methylation in cancer

  2014cites this paper
• Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

  2013cites this paper
• Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer

  2013cites this paper
• Aberrant DNA Methylation at Genes Associated with a Stem Cell-like Phenotype in Cholangiocarcinoma Tumors

  2013cites this paper
• The significance of genetics for cholangiocarcinoma development.

  2013influential citation
• P16 Hypermethylation Predicts Surgical Outcome Following Curative Resection of Mid/Distal Bile Duct Cancer

  2013cites this paper
• Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma

  2013cites this paper
• Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

  2013cites this paper
• Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients

  2013cites this paper
• The role of the hepatitis viruses in cholangiocarcinoma

  2013cites this paper
• Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumours

  2013cites this paper
• Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma.

  2013cites this paper
• DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer

  2012cites this paper
• Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

  2012cites this paper
• Genetic profiling of intrahepatic cholangiocarcinoma

  2012cites this paper
• Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity.

  2012cites this paper
• Exposure to Nano-Sized Particles and the Emergence of Contemporary Diseases with a Focus on Epigenetics

  2012cites this paper
• Gene expression and epigenetic changes by furan in rat liver.

  2012cites this paper
• Transfection of HCVc improves hTERT expression through STAT3 pathway by epigenetic regulation in Huh7 cells

  2012cites this paper
• IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications

  2012cites this paper
• Oxidative stress in ulcerative colitis: an old concept but a new concern

  2012cites this paper
• Avaliação do perfil de metilação e expressão do gene CDH1 em Cebus apella como modelo experimental para câncer gástrico

  2012cites this paper
• Mechanisms of GI Malignancies

  2012cites this paper
• Epigenetics in Cholangiocarcinoma

  2012cites this paper
• Molecular Carcinogenesis of Cholangiocarcinoma II: Associated Genes in the Genesis of Cholangiocarcinoma

  2012cites this paper
• Cholangiocarcinoma—controversies and challenges

  2011cites this paper
• CpG-island methylation study of liver fluke-related cholangiocarcinoma

  2011cites this paper
• Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.

  2011cites this paper
• Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.

  2011cites this paper
• Cholangiocarcinoma: principles and current trends.

  2011cites this paper
• P 16 and MGMT hypermethylation predicts surgical outcomes in curative resected mid / distal bile duct cancer

  2011cites this paper
• Increased skin papilloma formation in mice lacking glutathione transferase GSTP.

  2011cites this paper
• Role of MiRNA in liver cell proliferation during hepatic regeneration and cancer.

  2010cites this paper
• Low Doses of the Carcinogen Furan Alter Cell Cycle and Apoptosis Gene Expression in Rat Liver Independent of DNA Methylation

  2010influential citation
• Aberrant DNA methylation of integrin α4: a potential novel role for metastasis of cholangiocarcinoma

  2010cites this paper
• Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.

  2010cites this paper
• Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics

  2010cites this paper